Consultation Goals
- Understanding the Recurrence Score result.
- Determining the benefit of adding chemotherapy to hormone therapy.
- Personalizing the treatment plan based on tumor genetics.
Book Oncotype DX Consultation | Lahalak Medical Platform
A specialized clinical consultation to evaluate the 21-gene recurrence score, helping early-stage breast cancer patients make informed decisions about adjuvant chemotherapy based on their unique genomic profile.
Scientific name: Oncotype DX Breast Cancer Genomic Test Consultation
A professional session with an oncologist to interpret Oncotype DX results. It assesses the risk of recurrence and determines the necessity of chemotherapy, ensuring personalized cancer care.
Service type
Medical Consultation
Duration
30-45 minutes
Fasting
No fasting required
Included Services
- Review of genomic report
- Medical history assessment
- Determining chemotherapy necessity
Medical Service Information
Target Groups
- Patients with early-stage breast cancer.
- Hormone receptor-positive (ER+) cases.
- HER2-negative breast cancer cases.
Frequently Asked Questions
- Does the consultation replace the test? No, it is for interpreting the lab results.
- Can I have the consultation remotely? Yes, it is available via video call or home visit.
Conditions & Notices
- Provide original Oncotype DX report
- Availability of histopathology report
Medical services you might also like
